Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.33 USD | +0.94% | +0.34% | -12.76% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.76% | 1.39B | |
+9.63% | 115B | |
+13.16% | 107B | |
-13.40% | 22.31B | |
-3.46% | 21.6B | |
-5.29% | 18.23B | |
-38.57% | 17.62B | |
+8.18% | 14.26B | |
+34.60% | 12.37B | |
-26.51% | 8.28B |
- Stock Market
- Equities
- AKRO Stock
- News Akero Therapeutics, Inc.
- Morgan Stanley Adjusts Akero Therapeutics Price Target to $26 From $29, Maintains Equalweight Rating